Novozymes A/S

CSE:NZYM-B.CO

360 (DKK) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) DKK.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 4,6034,4564,2174,6234,5294,3674,2864,3713,8343,7613,5803,7763,4463,4313,3493,7863,7313,7043,4583,4813,7143,6583,4983,5203,6733,5803,5383,7403,7143,3903,4293,6093,4523,5223,4493,5793,1813,1843,0613,0332,9402,9363,0252,845
Cost of Revenue 2,1182,0581,8812,1202,1062,0191,9071,9441,6701,5841,4791,5801,5351,5061,4921,6261,6211,6471,5711,5481,5481,5421,5121,4871,5411,5031,4801,5791,5671,4481,4311,5301,2881,4521,4441,5151,2941,3721,2901,2791,2681,2791,2931,190
Gross Profit 2,4852,3982,3362,5032,4232,3482,3792,4272,1642,1772,1012,1961,9111,9251,8572,1602,1102,0571,8871,9332,1662,1161,9862,0332,1322,0772,0582,1612,1471,9421,9982,0792,1642,0702,0052,0641,8871,8121,7711,7541,6721,6571,7321,655
Gross Profit Ratio 0.540.5380.5540.5410.5350.5380.5550.5550.5640.5790.5870.5820.5550.5610.5540.5710.5660.5550.5460.5550.5830.5780.5680.5780.580.580.5820.5780.5780.5730.5830.5760.6270.5880.5810.5770.5930.5690.5790.5780.5690.5640.5730.582
Reseach & Development Expenses 524461515517535475498493512435499563530477470460443520545458449500465451493440477503475432456502451471507467536443441421383369404372
General & Administrative Expenses 241236231251242253238219261201199198194179168198181246209191220192192188197190224220200178214218217220213226229209212207214200215195
Selling & Marketing Expenses 601531594639561542552585609456432439365383374430385444399399395404369385375398405441426386392418396387380408314350363379383332381380
SG&A 842767825890803795790804903657631637567562542628571690608590604596561573592588629661608564606636628607593634556559575586618532596575
Other Expenses 00000000000000000000000000000000000000000000
Operating Expenses 1,4161,2141,3251,3031,5349501,3211,3411,3401,1141,0961,0801,0921,0221,0371,1281,0651,2717541,1021,1631,1371,0401,0221,1601,0721,1221,1781,1219801,0391,1191,2911,1081,1151,1411,0989669938399419321,035988
Operating Income 1,5311,0228651,1341,0901,3181,1101,1426921,0959901,1178078948671,0951,0928527498951,1441,0419571,0161,0881,0599631,0101,1209739619501,1211,013930979972831787747682755734709
Operating Income Ratio 0.3330.2290.2050.2450.2410.3020.2590.2610.180.2910.2770.2960.2340.2610.2590.2890.2930.230.2170.2570.3080.2850.2740.2890.2960.2960.2720.270.3020.2870.280.2630.3250.2880.270.2740.3060.2610.2570.2460.2320.2570.2430.249
Total Other Income Expenses Net -145-36-213-16013470-63-6679-413-11-1-6-59-76-33-81360-35-140-63-12-7-120-59-32-33-99-19-105-251-54-50-67-190-3-2015525-44-54-48
Income Before Tax 9231,1487981,0401,0451,3881,0471,0767711,0549931,1068068888081,0191,0597711,1098601,0049789451,0099681,0009319771,021954951955870959880912782828767902707711680661
Income Before Tax Ratio 0.2010.2580.1890.2250.2310.3180.2440.2460.2010.280.2770.2930.2340.2590.2410.2690.2840.2080.3210.2470.270.2670.270.2870.2640.2790.2630.2610.2750.2810.2770.2650.2520.2720.2550.2550.2460.260.2510.2970.240.2420.2250.232
Income Tax Expense 228219184239168235230237148211199221152177162204137133211163167171169202174181196205216205200210177216198205179191176208144143124147
Net Income 6989366067848831,152809832625842794885654711645815922638898696837807776806794818736771806750750744692743682706603639591693561568557514
Net Income Ratio 0.1520.210.1440.170.1950.2640.1890.190.1630.2240.2220.2340.190.2070.1930.2150.2470.1720.260.20.2250.2210.2220.2290.2160.2280.2080.2060.2170.2210.2190.2060.20.2110.1980.1970.190.2010.1930.2280.1910.1930.1840.181
EPS 2.523.382.192.833.194.142.92.982.243.012.833.152.332.532.282.883.262.233.122.412.882.762.652.732.682.762.472.582.682.482.462.432.252.412.22.271.942.031.872.181.761.791.761.62
EPS Diluted 2.513.372.182.823.184.142.92.982.243.012.833.152.332.532.282.883.252.233.122.412.892.762.652.732.692.762.472.582.692.482.462.432.252.412.22.271.932.031.872.181.761.791.761.62
EBITDA 1,0411,3469821,2661,1191,6951,4871,5037881,4481,3681,4579241,2091,1721,3941,1581,1181,0511,1651,3201,3171,1941,2701,3171,3001,2061,2651,3411,2111,1941,1811,3021,2431,2151,2061,0961,0781,061941848940926884
EBITDA Ratio 0.2260.3020.2330.2740.2470.3880.3470.3440.2060.3850.3820.3860.2680.3520.350.3680.310.3020.3040.3350.3550.360.3410.3610.3590.3630.3410.3380.3610.3570.3480.3270.3770.3530.3520.3370.3450.3390.3470.310.2880.320.3060.311